However, despite its promising potential as a treatment tool for various brain diseases, efforts to use BDNF in the treatment of neurological diseases have complicated problems of application because BDNF has a short half-life (within 10 min) and is unable to cross the blood-brain barrier (BBB) due to its large size (27 kDa) [24]. Here, BDNF is linked to nervous system disorder.